Special Funding II

Created on:2020-12-03 16:17

logo

December 03rd,2020 Press Release

 

Another Special Funding , Great Bay Bio's Image Recognition-based Cell Expression Prediction Technology and Application was Granted the Second Batch of Guangdong Enterprises' Science and Technology Commissioners  Program in 2020

 

[2020/12/3, Dongguan]On November 19, the project of "Image Recognition Based Cell Expression Prediction Technology and Application" of Dongguan Taili Biotech Co, Ltd., a subsidiary of Great Bay Bio, was awarded the second batch of 2020 Guangdong Enterprise Science and Technology Commissioner Program. This is the second time this month that Great Bay Bio has received this grant. 

 

 

The image recognition-based cell expression prediction technology and application project is one of the core technologies of Klone4.0, a cell line development platform developed by Great Bay Bio, which can screen hundreds of thousands of cells at a time and obtain cell images. Based on this, Klone4.0 platform utilizes AI technology to rapidly analyze, locate, and select high-yielding cells through AI and precise cell selection technology to obtain high-yielding, high-quality cell lines in four hours, realizing the intelligent application of cell line selection.

 

More stories

Special Funding丨Great Bay Bio Clinical Research Project won the First Batch of 2020 Guangdong Enterprise Science and Technology Commissioner Program.

 

About Guangdong Enterprise Science and Technology Commissioner Program

In order to implement the important instructions given by President Xi Jinping on the 20th anniversary of the implementation of the science and technology commissioner system, carry out the "Several Measures on Scientific and Technological Innovation to Support the Resumption of Work and the Smooth Operation of the Economy" (No. 67 [2020] of the State Science and Technology Development Zone) and the "Notice of the General Office of the Ministry of Science and Technology on the Special Action of Science and Technology Personnel Service Enterprises" (No. 59 [2020] of the State Science and Technology Office),we are actively doing our best to meet the requirements of the following key work of science and technology innovation deployed by the Provincial Science and Technology Innovation Conference, including reforming and improving the province's enterprise science and technology commissioner system, exploring a new model of enterprise science and technology commissioner "oriented to the technology needs of enterprises", attracting global scientific and technological talents to serve Guangdong enterprises' innovation and development, and further developing and strengthening the province's enterprise science and technology commissioner team. To support enterprises to achieve high quality development through innovation and provide strong support for the province to accelerate the implementation of innovation-driven development strategy, the Guangdong Provincial Department of Science and Technology on organizing the 2020 Guangdong Enterprise Science and Technology Commissioner Program was officially launched.

 

About Great Bay Bio

Headquartered in Hong Kong, GBB is a high-tech enterprise dedicated to applying artificial intelligence and other cutting-edge technologies to CMC (Chemistry, Manufacturing, Control) for development of biopharmaceuticals and other blue ocean bio-products (such as cell therapy), ultimately solving numerous pain points of CMC development, including high failure rates, long development timeline and high costs. Since the company’s establishment, it has obtained massive data from conventional biologics development in its 3100 m2 CMC facilities in Dongguan, PRC. With over RMB 300M investment, the facilities bolster advance equipment from world-renowned manufacturers. GBB has also successfully brought a number of biologic products to NDA stage, some of which are classified as national class I innovative drugs. Currently, the company has created the intelligent centralized database, where deep learning is being performed to create next generation AI-enabled CMC platforms. To learn more, please visit http://www.greatbay-bio.com.

 

PR Contact: Miss Liu 

Email: yt.liu@greatbay-bio.com

Home    News    Special Funding II
PV:0
Collect